These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4480288)

  • 1. Effects of benzoctamine and chlordiazepoxide on turnover and uptake of 5-hydroxytryptamine in the brain.
    Lippmann W; Pugsley TA
    Br J Pharmacol; 1974 Aug; 51(4):571-5. PubMed ID: 4480288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of taclamine (AY-22,214), a new psychoactive agent, on catecholamine and serotonin metabolism.
    Pugsley TA; Lippmann W
    Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):73-87. PubMed ID: 1156020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between chlordiazepoxide and CL 218,872, a synthetic non-benzodiazepine ligand for benzodiazepine receptors, on serotonin and catecholamine turnover in brain.
    McElroy JF; Feldman RS; Meyer JS
    Psychopharmacology (Berl); 1986; 88(1):105-8. PubMed ID: 2868479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pyrroxan and chlordiazepoxide on biogenic amine metabolism in the rat brain.
    Pugsley TA; Lippmann W
    Psychopharmacology (Berl); 1976 Nov; 50(2):113-8. PubMed ID: 12528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some peripheral pharmacological characteristics of benzoctamine.
    Jaques R; Rüegg M
    Pharmacology; 1971; 6(2):89-98. PubMed ID: 4400350
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in regional concentrations in the rat brain of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid during the development of tolerance to the sedative action of chlordiazepoxide.
    Lister RG; File SE
    J Pharm Pharmacol; 1983 Sep; 35(9):601-3. PubMed ID: 6195324
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of restraint stress and anxiolytics on 5-HT turnover in rat brain.
    Mitchell SN; Thomas PJ
    Pharmacology; 1988; 37(2):105-13. PubMed ID: 2905483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of serotonin receptor blocking agents--cyproheptadine and danitracen--on serotonin turnover in the rat brain.
    Golembiowska-Nikitin K; Wiszniowska G; Marchaj J
    Pol J Pharmacol Pharm; 1977; 29(5):485-95. PubMed ID: 145590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the central antiserotonin activity of benzoctamine and opipramol.
    Przegaliński E; Baran L; Palider W; Bigajska K
    Pol J Pharmacol Pharm; 1978; 30(6):781-90. PubMed ID: 582625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlordiazepoxide loses its anxiolytic action with long-term treatment.
    Vellucci SV; File SE
    Psychopharmacology (Berl); 1979 Mar; 62(1):61-5. PubMed ID: 35809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacology of benzoctamine, a new psychotropic agent].
    Takahama K; Miyata T; Kase Y
    Nihon Yakurigaku Zasshi; 1977 Mar; 73(2):151-76. PubMed ID: 577914
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the role of ACTH and of 5-HT in anxiety, using an animal model.
    File SE; Vellucci SV
    J Pharm Pharmacol; 1978 Feb; 30(2):105-10. PubMed ID: 24093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra.
    Kantor S; Jakus R; Molnar E; Gyongyosi N; Toth A; Detari L; Bagdy G
    J Pharmacol Exp Ther; 2005 Nov; 315(2):921-30. PubMed ID: 16085759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antinociceptive action of a novel anxiolytic and tensiolytic drug (benzoctamine) in two different writhing syndromes.
    Jaques R; Helfer H
    Pharmacology; 1971; 6(1):35-40. PubMed ID: 5171843
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological investigations with benzoctamine (Tacitin), a new psycho-active agent.
    Baltzer V; Bein HJ
    Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):25-41. PubMed ID: 4197881
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of serotonin depletion on rat behavior in the Vogel test and brain 3H-zolpidem binding.
    Nazar M; Siemiatkowski M; Bidziński A; Członkowska A; Sienkiewicz-Jarosz H; Płaźnik A
    J Neural Transm (Vienna); 1999; 106(5-6):355-68. PubMed ID: 10443543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of fenfluramine on monoamine stores of rat tissues.
    Costa E; Groppetti A; Revuelta A
    Br J Pharmacol; 1971 Jan; 41(1):57-64. PubMed ID: 5547762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin, but not dopamine, controls the stress response and anxiety-like behavior in the crayfish Procambarus clarkii.
    Fossat P; Bacqué-Cazenave J; De Deurwaerdère P; Cattaert D; Delbecque JP
    J Exp Biol; 2015 Sep; 218(Pt 17):2745-52. PubMed ID: 26139659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
    Claassen V; Davies JE; Hertting G; Placheta P
    Br J Pharmacol; 1977 Aug; 60(4):505-16. PubMed ID: 302726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.